LYON, FRANCE AND NEW YORK, NY (PRWEB) JULY 11, 2016 The Medicrea Group (Alternext Paris: FR0004178572 – ALMED), PEA- PME eligible, pioneering the development and manufacture of patient-specific analytical services and implant solutions for the treatment of spinal conditions, announces sales for the first half of 2016. Medicrea First Half Sales: H1 2015 Sales = […]